Respiratory test portfolio designed to maximise sample throughput and ensure clinically relevant turn around times for critical patient results.
Two-well, multiplex qPCR assay for the detection of Influenza A, Influenza B, Rhinoviruses (A & B), Respiratory Syncytial Viruses (A & B), Human metapneumovirus, Adenoviruses, and Human parainfluenza viruses 1, 2, 3 and 4.